Active Pharmaceutical Ingredients
Ciprofloxacin Taste Mask Granules are ready-to-use pharmaceutical intermediates designed to improve the palatability of ciprofloxacin in oral dosage forms. These granules are formulated with effective taste-masking agents and functional excipients to mask the bitter taste of ciprofloxacin, enhancing patient compliance, especially in pediatric and geriatric populations. The granules exhibit excellent flowability and compressibility, making them suitable for direct compression into tablets, capsule filling, or sachet formulations. The formulation ensures immediate release for rapid antibacterial action.
| Component | Function |
|---|---|
| Ciprofloxacin | Active Pharmaceutical Ingredient (API) – Fluoroquinolone antibiotic used to treat bacterial infections |
| Taste-Masking Polymer (e.g., Eudragit E / Cellulose Derivative) | Taste-Masking Agent – Forms a protective barrier to prevent bitter taste in the mouth |
| Mannitol / Sucralose / Flavored Agents | Sweeteners & Flavoring Agents – Improve palatability and patient compliance, especially in pediatric use |
| Pregelatinized Starch / Starch 1500 | Binder & Disintegrant – Provides structural integrity and ensures granule re-dispersibility |
| Colloidal Silicon Dioxide | Glidant – Enhances powder flow properties and prevents clumping during handling |
Outsourcing Taste Mask Granules through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromise on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Ciprofloxacin Taste Mask Granules or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
These are pharmaceutical intermediates designed to mask the bitter taste of ciprofloxacin, making it easier for patients, especially children and the elderly, to take oral suspensions or sprinkle formulations.
Yes, microbial limit testing and preservative effectiveness studies are conducted as per pharmacopeial standards.
Content uniformity is ensured through validated blending and granulation processes, supported by batch-wise analytical data.
MOQ is negotiable depending on market requirements.